Evidence map›Paper›PMID 42290902›Full record

ArticleInterventional pain medicine2026

Early pain-response trajectories after basivertebral nerve ablation and their relationship to 12-month clinical outcomes.

Charles A Odonkor, Muhammad Uzair Siddique, Mustafa Reha Dodurgali, Sarvesh Palaniappan, Cameron Harris, Selaiman Noori, Jack Diep, Jared Rosenberg, Sudhir K Kadian, Mannat Kadian and 3 more

Abstract read
In one paragraph

Article in Interventional pain medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Charles A OdonkorDepartment of Orthopaedics and Rehabilitation, Division of Physiatry, Interventional Pain Medicine, Yale New Haven Hospital, 20 York Street, New Haven, CT, 06510, United States.
Muhammad Uzair SiddiqueDepartment of Orthopaedics and Rehabilitation, Yale University School of Medicine, 333 Cedar Street, New Haven, CT, 06510, United States.
Mustafa Reha DodurgaliDepartment of Orthopaedics and Rehabilitation, Yale University School of Medicine, 333 Cedar Street, New Haven, CT, 06510, United States.
Sarvesh PalaniappanBoston University Chobanian and Avedisian School of Medicine, 72 East Concord St., Boston, MA, 02118, United States.
Cameron HarrisValley Health System Graduate Medical Education, 6655 S. Cimarron Rd STE 100, Las Vegas, NV, 89113, United States.
Selaiman NooriLakeside Spine & Pain, 1720 Mesquite Ave, Lake Havasu City, AZ, 86403, United States.
Jack DiepLakeside Spine & Pain, 1720 Mesquite Ave, Lake Havasu City, AZ, 86403, United States.
Jared RosenbergDepartment of Anesthesiology, Greenwich Hospital, 5 Perryridge Road, 2nd Floor, Greenwich, CT, 06830, United States.
Sudhir K KadianDepartment of Anesthesiology and Pain Medicine, Northeast Medical Group, 194 Howard Street, New London, CT, 06320, United States.
Mannat KadianUniversity of Connecticut, 2131 Hillside Road, Storrs, CT, 06269, United States.
David W LeeDepartment of Physical Medicine and Rehabilitation, University of California, Irvine, 101 the City Dr S Building 3, Orange, CA, 92868, United States.
Brian DurkinNew York Spine and Pain Specialists, 5316 Nesconset Highway, Suite 100, Port Jefferson Station, NY, 11776, United States.
Peter G WhangDepartment of Orthopaedics and Rehabilitation, Division of Spine Surgery, Yale University School of Medicine, 20 York Street, New Haven, CT, 06510, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Basivertebral nerve ablation (BVNA) is an established treatment for vertebrogenic low back pain, but the relationship between early post-procedural response and longer-term outcomes remains unclear. Objective: To evaluate whether early pain-response trajectories following BVNA were associated with 12-month clinical outcomes and to identify a clinically useful time point for reassessment. Methods: This prospective multicenter observational cohort study included 140 patients with MRI-confirmed Modic type 1 or 2 changes treated with BVNA between April 2024 and April 2025. Patients reported weekly percent pain relief through 8 weeks, followed by assessments at 3, 6, and 12 months. The primary outcome was ≥50% pain relief at 12 months. Discriminative performance of Week 3 and Week 6 responses was assessed using sensitivity, specificity, likelihood ratios, and receiver operating characteristic analysis. Time to first ≥50% relief was evaluated using Kaplan-Meier methods. Secondary outcomes included changes in Numeric Rating Scale (NRS), Oswestry Disability Index (ODI), Patient Global Impression of Change (PGIC), and post-procedural healthcare utilization. Results: At 12 months, 82.1% achieved ≥50% pain relief. The mean NRS improved by 4.3 points and the mean ODI improved by 34 points, with 84.3% and 94.3% achieving Minimally Clinically Important Difference (MCID) thresholds, respectively. The Week 3 response was linked to increased likelihood of 12-month success (LR Conclusion: Early pain-response trajectories following BVNA were associated with 12-month outcomes. Clinically meaningful submaximal improvement (≥30%) identified patients who attained durable benefit, whereas absence of early improvement was linked to a lower likelihood of long-term success. These findings suggest that meaningful response signals may emerge before conventional ≥50% responder thresholds are reached, providing a more nuanced framework for interpreting early post-procedural response.

Indexed as

Basivertebral nerve ablationHealthcare utilizationLongitudinal outcomesPain-response trajectory early responseVertebrogenic low back pain

Identifiers

PMID42290902
PMCPMC13263762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.